BCM Oncology Scholars Training Program

项目总结/摘要 肿瘤学的转化研究培训需要一个指导计划， 来自多个学科的组件。近几年来， 具有临床和实验室研究专长的年轻研究人员。为了 增加有才华的医生科学家和博士的储备。翻译科学家 癌症研究，我们需要改善培训机会。肿瘤学学者 培训计划旨在满足两个医学博士的需求。(or医学博士/博士）和博士 实习生该计划由五个科学研究主题组成，包括：（1） “组学”科学（基因组学、蛋白质组学和代谢组学）;（2）癌症信号 途径;（3）干细胞和发展;（4）治疗和诊断;（5）癌症 流行病学和预防。从贝勒血液学/肿瘤学研究员的每一个班级， 我们将选择一名学者，并提供三年的研究支持和指导， 从奖学金的后半段开始，一直延续到前18个月。 初级教员的职位培养博士肿瘤学的转化研究，我们将 也选择一个博士学位。博士后学者每年从博士后池通过 公开竞争，并支持她/他的转化癌症研究三年。每个 学者学员将接受肿瘤学研究培训计划，包括教学 课程，职业发展技能和指导实验室研究。每一位学员将 接受针对学员具体兴趣的指导。通过共同- 医学博士的导师和博士学者之间的研究导师和临床 教师，和一个程序特定的研究研讨会系列，拟议的T32将作为 一个平台，为我们的学员发展转化癌症合作研究， 培养他们的职业发展。

Project Summary/Abstract Translational research training in oncology requires a mentoring program with components from multiple disciplines. In recent years, there has been a shortage of young investigators with both clinical and laboratory research expertise. In order to increase the pool of talented physician-scientists and Ph.D. scientists in translational cancer research we need to improve training opportunities. The BCM Oncology Scholars Training Program aims to address the needs of both M.D. (or M.D./Ph.D.) and Ph.D. trainees. The program is composed of five scientific research themes including: (1) "Omics" sciences (genomics, proteomics and metabolomics); (2) Cancer signaling pathways; (3) Stem cells and development; (4) Therapeutics and diagnostics; (5) Cancer epidemiology and prevention. From each class of Baylor hematology/oncology fellows, we will select a scholar and provide three years of research support and mentoring, starting in the second half of the fellowship and extending into the first eighteen months of a junior faculty position. To train Ph.D. the translational research in oncology, we will also select a Ph.D. postdoctoral scholar each year from the BCM postdoctoral pool via open competition and support her/his translational cancer research for three years. Each scholar trainee will receive a training program in oncological research including didactic courses, career development skills and mentored laboratory research. Each trainee will receive mentorship tailored to the specific interests of the trainees. Through co- mentorship for the M.D. and Ph.D. scholars between research mentors and clinical faculty, and a program-specific research seminar series, the proposed T32 will serve as a platform to develop translational cancer collaborative research for our trainees and to nurture their career development.